Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 28

Understand MYD88 L265P testing in Waldenström macroglobulinemia and lymphoplasmacytic lymphoma, including positive and negative results, assay sensitivity, and CXCR4 context.

MYD88 L265P Mutation Test: Waldenstrom Macroglobulinemia, Lymphoplasmacytic Lymphoma, and Mutation Meaning

Myelodysplastic Syndrome (MDS) Mutation Panel: Risk Genes, Prognosis, and Molecular Profile

Understand JAK2, CALR and MPL MPN panel testing, including positive and negative results, triple-negative disease, molecular diagnosis of PV, ET and myelofibrosis.

Myeloproliferative Neoplasm Panel: JAK2, CALR, MPL, and Molecular Diagnosis

Understand NPM1 mutation testing in AML, including mutation status, prognosis, co-mutations, MRD monitoring, molecular relapse, and treatment decisions.

NPM1 Mutation Test: AML Prognosis, MRD, Mutation Status, and Result Meaning

Learn how PML-RARA testing confirms acute promyelocytic leukemia, how PCR and FISH differ, and how molecular MRD monitoring detects persistent or recurrent APL.

PML-RARA Fusion Test: Acute Promyelocytic Leukemia, Gene Fusion, and MRD Monitoring

Understand RUNX1 mutation testing in AML and MDS, including result meaning, modern classification, prognosis, germline risk, and follow-up implications.

RUNX1 Mutation Test: AML, Myelodysplastic Syndrome Risk, and Mutation Meaning

Understand serum free light chain testing for kappa, lambda, and the ratio, including kidney effects, myeloma and MGUS patterns, and treatment monitoring.

Serum Free Light Chain Test: Kappa, Lambda, Ratio, Myeloma, and Plasma...

Understand serum immunofixation results, including monoclonal protein type, IgG/IgA/IgM and kappa/lambda patterns, myeloma testing, MGUS, and follow-up.

Serum Immunofixation Test: Monoclonal Protein Type, Myeloma, and Plasma Cell Disorders

Learn how to read an SPEP test, including M-spike meaning, monoclonal versus polyclonal patterns, myeloma and MGUS evaluation, limitations, and follow-up.

Serum Protein Electrophoresis (SPEP) Test: M Protein, Myeloma, and Monoclonal Gammopathy

Understand SOX11 testing in mantle cell lymphoma, including positive nuclear staining, cyclin D1-negative MCL, SOX11-negative subtypes, diagnosis, and prognosis.

SOX11 Test: Mantle Cell Lymphoma Marker, Positive Staining, and Diagnostic Meaning

Understand TET2 mutation testing, including CHIP and CCUS, AML and MDS associations, variant allele frequency, cancer risk, prognosis, and appropriate follow-up.

TET2 Mutation Test: Blood Cancer, Clonal Hematopoiesis, Myeloid Neoplasms, and Mutation...

Understand TP53 mutation testing in blood cancer, including AML and MDS risk, multi-hit disease, del(17p), VAF, clonal hematopoiesis, and treatment impact.

TP53 Mutation Test for Blood Cancer: High-Risk Leukemia, Mutation Status, and...

Understand TP53 testing in CLL, including del(17p), TP53 mutations, low-VAF clones, when to repeat testing, targeted treatment choices, and modern prognosis.

TP53 Test for CLL: del17p, TP53 Mutation, Treatment Risk, and Prognosis

Understand UPEP testing for Bence Jones protein, including 24-hour urine collection, monoclonal light chains, myeloma monitoring, kidney risk, and result meaning.

Urine Protein Electrophoresis (UPEP) Test: Bence Jones Protein, Myeloma Monitoring, and...

$AFP-L3 testing measures the AFP-L3 fraction linked with hepatocellular carcinoma risk. Learn what high AFP-L3% means, common cutoffs, limitations, and next steps.$

AFP-L3 Test: Liver Cancer Risk, AFP Fraction, HCC Monitoring, and Result...

BRAF V600E testing in colon cancer helps guide prognosis, targeted therapy, and MLH1-deficient Lynch syndrome workup. Learn what positive and negative results mean.

BRAF V600E Test for Colon Cancer: Mutation Status, Prognosis, and Lynch...

1...272829...137 Page 28 of 137